share_log

HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $25 Price Target

HC Wainwright & Co. Reiterates Buy on BriaCell Therapeutics, Maintains $25 Price Target

HC Wainwright & Co.重申买入BriaCell Therapeutics,维持25美元的目标股价
Benzinga ·  2023/06/28 06:12

HC Wainwright & Co. analyst Emily Bodnar reiterates BriaCell Therapeutics (NASDAQ:BCTX) with a Buy and maintains $25 price target.

HC Wainwright & Co. 分析师艾米丽·博德纳尔重申了BriaCell Therapeutics(纳斯达克股票代码:BCTX)的买入,并维持25美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发